Adenovirus-adeno-associated virus hybrid for large-scale recombinant adeno-associated virus production

Human Gene Therapy

Volumn 20, Issue 9, 2009, Pages 922-929

  Zhang, Hongwei ^a   Xie, Jun ^a   Xie, Qing ^a,b   Wilson, James M ^c   Gao, Guangping ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; PARVOVIRUS VECTOR;

BIOLOGICAL MODEL; COLUMN CHROMATOGRAPHY; DRUG MANUFACTURE; GENE AMPLIFICATION; GENE THERAPY; HUMAN; HYBRID; HYBRIDIZATION; NONHUMAN; REVIEW; VIRUS HYBRID; VIRUS RECOMBINANT; VIRUS RECOMBINATION;

ANIMALS; BIOTECHNOLOGY; CELL LINE; CERCOPITHECUS AETHIOPS; DEPENDOVIRUS; GENE THERAPY; GENETIC VECTORS; HELA CELLS; HUMANS; RECOMBINATION, GENETIC; VERO CELLS;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; ANIMALIA;

EID: 70249151690     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.125     Document Type: Review

References (45)

1. Beall, C.J., Johnson, P.R., and Clark, K.R. (2007). High titer adeno-associated viral vector production by a Vero-derived producer cell line. Presented at the 10th Annual Meeting of American Society of Gene Therapy, Seattle, WA, May 30-June 3, 2007.
2. Blouin, V., Brument, N., Toublanc, E., Raimbaud, I., Moullier, P., and Salvetti, A. (2004). Improving rAAV production and pu-rification: Towards the definition of a scaleable process. J. Gene Med. 6(Suppl. 1), S223-S228.
3. Carter, B.J. (1990). Adeno-associated virus helper functions. In Tijssen, P., ed. CRC Handbook of Parvoviruses (CRC Press, Boca Raton, FL) pp. 255-282.
4. Carter, B.J., Mendelson, E., and Trempe, J.P. (1990). AAV DNA replication, integration, and genetics. In Tijssen, P., ed. CRC Handbook of Parvoviruses (CRC Press, Boca Raton, FL) pp. 169-226.
5. Clark, K.R. (2002). Recent advances in recombinant adeno-associated virus vector production. Kidney Int. 61, S9-S15
6. Clark, K.R., Voulgaropoulou, F., Fraley, D.M., and Johnson, P.R. (1995). Cell lines for the production of recombinant adeno-associated virus. Hum. Gene Ther. 6, 1329-1341.
7. Conway, J.E., Zolotukhin, S., Muzyczka, N., Hayward, G.S., and Byrne, B.J. (1997). Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap. J. Virol. 71, 8780-8789.
8. Coura Rdos, S., and Nardi, N.B. (2007). The state of the art of adeno-associated virus-based vectors in gene therapy. Virol. J. 4, 99.
9. Fan, P.D., and Dong, J.Y. (1997). Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV. Hum. Gene Ther. 8, 87-98.
10. Fisher, K.J., Kelley, W.M., Burda, J.F., and Wilson, J.M. (1996). A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome. Hum. Gene Ther. 7, 2079-2087.
11. Gao, G., Qu, G., Burnham, M.S., Huang, J., Chirmule, N., Joshi, B., Yu, Q.C., Marsh, J.A., Conceicao, C.M., and Wilson, J.M. (2000a). Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo. Hum. Gene Ther. 11, 2079-2091.
12. Gao, G., Wilson, J.M., and Wivel, N.A. (2000b). Production of recombinant adeno-associated virus. In K. Maramorosch, F.A. Murphy, and A.J. Shatkin, eds. Advances in Virus Research (Academic Press, San Diego, CA) pp. 529-544.
13. Gao, G., Alvira, M.R., Somanathan, S., Lu, Y., Vandenberghe, L.H., Rux, J.J., Calcedo, R., Sanmiguel, J., Abbas, Z., and Wilson, J.M. (2003). Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc. Natl. Acad. Sci. U.S.A. 100, 6081-6086.
14. Gao, G., Vandenberghe, L.H., Alvira, M.R., Lu, Y., Calcedo, R., Zhou, X., and Wilson, J.M. (2004). Clades of adeno-associated viruses are widely disseminated in human tissues. J. Virol. 78, 6381-6388.
15. Gao, G., Vandenberghe, L.H., and Wilson, J.M. (2005). New recombinant serotypes of AAV vectors. Curr. Gene Ther. 5, 285-297.
16. Gao, G.P., Qu, G., Faust, L.Z., Engdahl, R.K., Xiao, W., Hughes, J.V., Zoltick, P.W., and Wilson, J.M. (1998). High-titer adeno-associated viral vectors from a Rep=Cap cell line and hybrid shuttle virus. Hum. Gene Ther. 9, 2353-2362.
17. Gao, G.P., Alvira, M.R., Wang, L., Calcedo, R., Johnston, J., and Wilson, J.M. (2002a). Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. U.S.A. 99, 11854-11859.
18. Gao, G.P., Lu, F., Sanmiguel, J.C., Tran, P.T., Abbas, Z., Lynd, K.S., Marsh, J., Spinner, N.B., and Wilson, J.M. (2002b). Rep=Cap gene amplification and high-yield production of AAV in an A549 cell line expressing Rep=Cap. Mol. Ther. 5, 644-649.
19. Giard, D.J., Aaronson, S.A., Todaro, G.J., Arnstein, P., Kersey, J.H., Dosik, H., and Parks, W.P. (1973). In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 51, 1417-1423.
20. Hermonat, P.L., Santin, A.D., and Zhan, D. (2000). Binding of the human papillomavirus type 16 E7 oncoprotein and the adeno-associated virus Rep78 major regulatory protein in vitro and in yeast and the potential for downstream effects. J. Hum. Virol. 3, 113-124.
21. Inoue, N., and Russell, D.W. (1998). Packaging cells based on inducible gene amplification for the production of adeno-associated virus vectors. J. Virol. 72, 7024-7031.
22. Liu, X., Voulgaropoulou, F., Chen, R., Johnson, P.R., and Clark, K.R. (2000). Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines. Mol. Ther. 2, 394-403.
23. Liu, X.L., Clark, K.R., and Johnson, P.R. (1999). Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus. Gene Ther. 6, 293-299.
24. McCarty, D.M., Monahan, P.E., and Samulski, R.J. (2001). Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther. 8, 1248-1254.
25. Mueller, C., and Flotte, T.R. (2008). Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther. 15, 858-863.
26. Negrete, A., and Kotin, R.M. (2007). Production of recombinant adeno-associated vectors using two bioreactor configurations at different scales. J. Virol. Methods 145, 155-161.
27. Negrete, A., Esteban, G., and Kotin, R.M. (2007). Process optimization of large-scale production of recombinant adeno-associated vectors using dielectric spectroscopy. Appl. Micro-biol. Biotechnol. 76, 761-772.
28. Nony, P., Tessier, J., Chadeuf, G., Ward, P., Giraud, A., Dugast, M., Linden, R.M., Moullier, P., and Salvetti, A. (2001). Novel cis-acting replication element in the adeno-associated virus type 2 genome is involved in amplification of integrated rep-cap sequences. J. Virol. 75, 9991-9994.
29. Ogston, P., Raj, K., and Beard, P. (2000). Productive replication of adeno-associated virus can occur in human papillomavirus type 16 (HPV-16) episome-containing keratinocytes and is augmented by the HPV-16 E2 protein. J. Virol. 74, 3494-3504.
30. Popescu, N.C., Dipaolo, J.A., and Amsbaugh, S.C. (1987). Integration sites of human papillomavirus 18 DNA sequences on HeLa cell chromosomes. Cytogenet. Cell Genet. 44, 58-62.
31. Qiao, C., Wang, B., Zhu, X., Li, J., and Xiao, X. (2002). A novel gene expression control system and its use in stable, high-titer 293 cell-based adeno-associated virus packaging cell lines. J. Virol. 76, 13015-13027.
32. Salvetti, A., Oreve, S., Chadeuf, G., Favre, D., Cherel, Y., Champion-Arnaud, P., David-Ameline, J., and Moullier, P. (1998). Factors influencing recombinant adeno-associated virus production. Hum. Gene Ther. 9, 695-706.
33. Schwarz, E., Freese, U.K., Gissmann, L., Mayer, W., Roggen-buck, B., Stremlau, A., and Zur Hausen, H. (1985). Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314, 111-114.
34. Tamayose, K., Hirai, Y., and Shimada, T. (1996). A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography. Hum. Gene Ther. 7, 507-513.
35. Tessier, J., Chadeuf, G., Nony, P., Avet-Loiseau, H., Moullier, P., and Salvetti, A. (2001). Characterization of adenovirus-induced inverted terminal repeat-independent amplification of integrated adeno-associated virus rep-cap sequences. J. Virol. 75, 375-383.
36. Urabe, M., Ding, C., and Kotin, R.M. (2002). Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum. Gene Ther. 13, 1935-1943.
37. Vandenberghe, L.H., Wilson, J.M., and Gao, G. (2009). Tailoring the AAV vector capsid for gene therapy. Gene Ther. 16, 311-319.
38. Walz, C., Deprez, A., Dupressoir, T., Durst, M., Rabreau, M., and Schlehofer, J.R. (1997). Interaction of human papillomavirus type 16 and adeno-associated virus type 2 co-infecting human cervical epithelium. J. Gen. Virol. 78, 1441-1452.
39. Wang, Z., Ma, H.I., Li, J., Sun, L., Zhang, J., and Xiao, X. (2003). Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther. 10, 2105-2111.
40. Wright, J.F. (2008). Manufacturing and characterizing AAV-based vectors for use in clinical studies. Gene Ther. 15, 840-848.
41. Wright, J.F. (2009). Transient transfection methods for clinical adeno-associated viral vector production. Hum. Gene Ther. 20, 698-706.
42. Xiao, W., Chirmule, N., Berta, S.C., McCullough, B., Gao, G., and Wilson, J.M. (1999). Gene therapy vectors based on adeno-associated virus type 1. J. Virol. 73, 3994-4003.
43. Yang, Q., Chen, F., and Trempe, J.P. (1994). Characterization of cell lines that inducibly express the adeno-associated virus Rep proteins. J. Virol. 68, 4847-4856.
44. Zaiss, A.K., and Muruve, D.A. (2008). Immunity to adeno-associated virus vectors in animals and humans: A continued challenge. Gene Ther. 15, 808-816.
45. Zhong, L., Li, B., Mah, C.S., Govindasamy, L., Agbandje-McKenna, M., Cooper, M., Herzog, R.W., Zolotukhin, I., Warrington, K.H., Jr., Weigel-Van Aken, K.A., Hobbs, J.A., Zolotukhin, S., Muzyczka, N., and Srivastava, A. (2008). Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses. Proc. Natl. Acad. Sci. U.S.A. 105, 7827-7832.